Burning Rock Biotech Ltd (BNR)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Latest BNR Insider Trades
Yusheng HanOpen-market purchase$216K
Yusheng HanYusheng HanYusheng HanYusheng HanYusheng HanYusheng HanYusheng HanBurning Rock Biotech Ltd is a cancer diagnostics company. The Group provides pharma research and development services, mainly cancer therapy selection tests services, companion diagnostics development services, and other service agreements with the combination of various customized tests services and analytical validation services, to pharmaceutical companies for developing new drugs for targeted therapies, immunotherapies on various types of cancers, and to hospitals for their studies on cancer diagnosis & treatment. It had three operating segments, including the Central laboratory business, the In-hospital business, & Pharma research & development services. It generates the majority of its revenue from the Central laboratory business. Its products are Pan-HEME, OncoScreen-WES, & others.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market purchase | 7 | 731,410 | $6.18M |
2 Form 4 filings on record, the earliest from Apr 2, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 24,760 | $8.74 | $216K | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 210,000 | $9.25 | $1.94M | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 111,110 | $9.00 | $1.00M | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 104,650 | $7.45 | $780K | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 5,990 | $7.50 | $45K | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 250,000 | $8.00 | $2.00M | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 24,900 | $8.00 | $199K | |
| Yusheng Han | Open-market purchase | Ordinary Shares (represented by American depositary shares) | 314,870 | $17.36 | $5.47M |
Burning Rock Biotech Ltd (BNR) had 1 insider filing in the last 90 days, with the most recent on 2026-07-02. The full record for BNR runs to 2 Form 4 filings, the earliest from 2026-04-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
7 insider purchases of BNR were filed in the last 90 days, totaling $6.18M.
No insider sales of BNR were filed in the last 90 days.
This page tracks BNR Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add BNR to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
